Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF-1 pathway under nutrient-deprived conditions

References

• Abdel-Wahab AF, Mahmoud W, Al-Harizy RM. 2019. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res. 150:104511.
   PubMed Web of Science ®Google Scholar
• Abrams SL, Follo MY, Steelman LS, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra M, Murata RM, et al. 2019. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Adv Biol Regul. 71:172–182.
   PubMedGoogle Scholar
• Albadari N, Deng S, Li W. 2019. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert Opin Drug Discov. 14(7):667–682.
   PubMed Web of Science ®Google Scholar
• Cao C, Su M. 2019. Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome. Exp Ther Med. 17(4):3009–3014.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu FX, Luo HL, Liu JJ, Luo T, Bai T, Li LQ, Fan XH. 2016. Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1. Am J Transl Res. 8(11):4932–4941.
   PubMed Web of Science ®Google Scholar
• Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC. 2015. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep. 42(4):841–851.
   PubMed Web of Science ®Google Scholar
• Del Portillo P, García-Morales L, Menéndez MC, Anzola JM, Rodríguez JG, Helguera-Repetto AC, Ares MA, Prados-Rosales R, Gonzalez-Y-Merchand JA, García MJ. 2018. Hypoxia is not a main stress when Mycobacterium tuberculosis is in a dormancy-like long-chain fatty acid environment. Front Cell Infect Microbiol. 8:449.
   PubMed Web of Science ®Google Scholar
• Fu L, Chen W, Guo W, Wang J, Tian Y, Shi D, Zhang X, Qiu H, Xiao X, Kang T, et al. 2013. Berberine targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and cytochrome-c/caspase signaling to suppress human cancer cell growth. PLoS One. 8(7):e69240.
   PubMed Web of Science ®Google Scholar
• Gao XL, Zhang M, Tang YL, Liang XH. 2017. Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis. Onco Targets Ther. 10:5219–5228.
   PubMed Web of Science ®Google Scholar
• Harada H, Inoue M, Itasaka S, Hirota K, Morinibu A, Shinomiya K, Zeng L, Ou G, Zhu Y, Yoshimura M, et al. 2012. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nat Commun. 3:783.
   PubMed Web of Science ®Google Scholar
• Hughes VS, Wiggins JM, Siemann DW. 2018. Tumor oxygenation and cancer therapy – then and now. BJR. 92(1093):20170955.
   Google Scholar
• Lindblom E, Toma-Dasu I, Dasu A. 2018. Accounting for two forms of hypoxia for predicting tumour control probability in radiotherapy: an in silico study. Adv Exp Med Biol. 1072:183–187.
   PubMed Web of Science ®Google Scholar
• Mao L, Chen Q, Gong K, Xu X, Xie Y, Zhang W, Cao H, Hu T, Hong X, Zhan YY. 2018. Berberine decelerates glucose metabolism via suppression of mTOR dependent HIF1alpha protein synthesis in colon cancer cells. Oncol Rep. 39(5):2436–2442.
   PubMed Web of Science ®Google Scholar
• Movafagh S, Crook S, Vo K. 2015. Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate. J Cell Biochem. 116(5):696–703.
   PubMed Web of Science ®Google Scholar
• Oh ET, Kim CW, Kim HG, Lee JS, Park HJ. 2017. Brusatol-mediated inhibition of c-Myc increases HIF-1α degradation and causes cell death in colorectal cancer under hypoxia. Theranostics. 7(14):3415–3431.
   PubMed Web of Science ®Google Scholar
• Okuyama H, Inoue M. 2011. Hypoxic microenvironment and cancer dormancy. Gan to Kagaku Ryoho. 38(10):1559–1564.
   PubMedGoogle Scholar
• Pan Y, Shao D, Zhao Y, Zhang F, Zheng X, Tan Y, He K, Li J, Chen L. 2017. Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK- HIF-1α. Int J Biol Sci. 13(6):794–803.
   PubMed Web of Science ®Google Scholar
• Schlaff CD, Krauze A, Belard A, O'Connell JJ, Camphausen KA. 2014. Bringing the heavy: carbon ion therapy in the radiobiological and clinical context. Radiat Oncol. 9(1):88.
   PubMedGoogle Scholar
• Sethi R, Mayadev J, Sethi S, Rash D, Chen LM, Brooks R, Ueda S, Hsu IC. 2019. Patterns of recurrence in node-positive cervical cancer patients treated with contemporary chemoradiation and dose escalation: a multi-institutional study. Pract Radiat Oncol. 9(2):e180–e186.
   PubMed Web of Science ®Google Scholar
• Yang X, Yang B, Cai J, Zhang C, Zhang Q, Xu L, Qin Q, Zhu H, Ma J, Tao G, et al. 2013. Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo. Cancer Biol Ther. 14(11):1068–1073.
   PubMed Web of Science ®Google Scholar
• Yang J, Yin J, Yan G, Huang D, Wang J. 2016. Postoperative chemoradiotherapy versus radiotherapy alone for cervical cancer: a systematic review and meta-analysis. J Obstet Gynaecol. 36(5):641–648.
   PubMedGoogle Scholar
• Yang Y, Zhang N, Li K, Chen J, Qiu L, Zhang J. 2018. Integration of microRNA-mRNA profiles and pathway analysis of plant isoquinoline alkaloid berberine in SGC-7901 gastric cancers cells. Drug Des Dev Ther. 12:393–408.
   PubMed Web of Science ®Google Scholar
• Zeng L, Morinibu A, Kobayashi M, Zhu Y, Wang X, Goto Y, Yeom CJ, Zhao T, Hirota K, Shinomiya K, et al. 2015. Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis. Oncogene. 34(36):4758–4766.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yang X, Zhang Q, Yang B, Xu L, Qin Q, Zhu H, Liu J, Cai J, Tao G, et al. 2014. Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1alpha expression. Acta Otolaryngol. 134(2):185–192.
   PubMed Web of Science ®Google Scholar
• Zhang D, Wang Y, Shi Z, Liu J, Sun P, Hou X, Zhang J, Zhao S, Zhou BP, Mi J. 2015. Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation. Cell Rep. 10(8):1335–1348.
   PubMed Web of Science ®Google Scholar
• Zhu C, Guo X, Luo L, Wu Z, Luo Z, Jiang M, Zhang J, Qin B, Shi Y, Lou Y, et al. 2019. Extremely effective chemoradiotherapy by inducing immunogenic cell death and radio-triggered drug release under hypoxia alleviation. ACS Appl Mater Interfaces. 11(50):46536–46547.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhao T, Itasaka S, Zeng L, Yeom CJ, Hirota K, Suzuki K, Morinibu A, Shinomiya K, Ou G, et al. 2013. Involvement of decreased hypoxia-inducible factor 1 activity and resultant G1-S cell cycle transition in radioresistance of perinecrotic tumor cells. Oncogene. 32(16):2058–2068.
   PubMed Web of Science ®Google Scholar